IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

Factor IX, Quantity: 3500 IU

Dostępny od:

CSL Behring Australia Pty Ltd

Forma farmaceutyczna:

Solution

Skład:

Excipient Ingredients:

Droga podania:

Intravenous

Sztuk w opakowaniu:

3500 IU

Typ recepty:

Not scheduled. Not considered by committee

Wskazania:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Podsumowanie produktu:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Registered

Data autoryzacji:

2020-11-19